Sana Biotechnology Stock Performance
| SANA Stock | USD 4.30 0.28 6.97% |
On a scale of 0 to 100, Sana Biotechnology holds a performance score of 9. The entity has a beta of 3.67, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Sana Biotechnology will likely underperform. Please check Sana Biotechnology's expected short fall, day median price, and the relationship between the potential upside and accumulation distribution , to make a quick decision on whether Sana Biotechnology's existing price patterns will revert.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Sana Biotechnology are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Sana Biotechnology sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 6.97 | Five Day Return 27.98 | Year To Date Return 160.61 | Ten Year Return (87.75) | All Time Return (87.75) |
1 | Acquisition by Bishop Hans Edgar of 5628 shares of Sana Biotechnology subject to Rule 16b-3 | 10/06/2025 |
2 | Citizens Maintains Sana Biotechnology Market Outperform Recommendation - Nasdaq | 10/30/2025 |
3 | Sana Biotechnology to Present at the TD Cowen Immunology Inflammation Summit | 11/04/2025 |
4 | Sana Biotechnology Given New 9.00 Price Target at HC Wainwright | 11/07/2025 |
5 | Quantum Computer That Could Hack Everyones Crypto Why Eric Jackson Is Betting On BTQ Technologies As His Next 100-Bagger | 11/10/2025 |
6 | Why Sana Biotechnology Inc. stock is a must watch in 2025 - Product Launch Weekly Stock Breakout Alerts - Fundao Cultural do Par | 11/14/2025 |
7 | Sana Biotechnology Assessing Valuation After Third Quarter Net Loss Narrows in 2025 | 11/17/2025 |
8 | Why Sana Biotechnology Inc. stock could benefit from AI revolution - 2025 Market Sentiment Free High Accuracy Swing Entry Alerts - newser.com | 11/19/2025 |
9 | Sana Biotechnology to Present at December 2025 Investor Conferences | 11/24/2025 |
| Begin Period Cash Flow | 137.3 M | |
| Total Cashflows From Investing Activities | 17.5 M |
Sana Biotechnology Relative Risk vs. Return Landscape
If you would invest 284.00 in Sana Biotechnology on September 1, 2025 and sell it today you would earn a total of 146.00 from holding Sana Biotechnology or generate 51.41% return on investment over 90 days. Sana Biotechnology is currently generating 0.873% in daily expected returns and assumes 6.9729% risk (volatility on return distribution) over the 90 days horizon. In different words, 62% of stocks are less volatile than Sana, and 83% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Sana Biotechnology Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sana Biotechnology's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Sana Biotechnology, and traders can use it to determine the average amount a Sana Biotechnology's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1252
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | SANA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.97 actual daily | 62 62% of assets are less volatile |
Expected Return
| 0.87 actual daily | 17 83% of assets have higher returns |
Risk-Adjusted Return
| 0.13 actual daily | 9 91% of assets perform better |
Based on monthly moving average Sana Biotechnology is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sana Biotechnology by adding it to a well-diversified portfolio.
Sana Biotechnology Fundamentals Growth
Sana Stock prices reflect investors' perceptions of the future prospects and financial health of Sana Biotechnology, and Sana Biotechnology fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Sana Stock performance.
| Return On Equity | -0.96 | ||||
| Return On Asset | -0.24 | ||||
| Current Valuation | 1.07 B | ||||
| Shares Outstanding | 266.37 M | ||||
| Price To Book | 5.86 X | ||||
| EBITDA | (255.33 M) | ||||
| Net Income | (266.76 M) | ||||
| Cash And Equivalents | 484.8 M | ||||
| Cash Per Share | 2.57 X | ||||
| Total Debt | 94.2 M | ||||
| Debt To Equity | 0.18 % | ||||
| Current Ratio | 5.09 X | ||||
| Book Value Per Share | 0.74 X | ||||
| Cash Flow From Operations | (223.15 M) | ||||
| Earnings Per Share | (0.96) X | ||||
| Market Capitalization | 1.15 B | ||||
| Total Asset | 501.02 M | ||||
| Retained Earnings | (1.6 B) | ||||
| Working Capital | 115.38 M | ||||
About Sana Biotechnology Performance
By analyzing Sana Biotechnology's fundamental ratios, stakeholders can gain valuable insights into Sana Biotechnology's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Sana Biotechnology has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Sana Biotechnology has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.89) | (0.93) | |
| Return On Capital Employed | (0.60) | (0.63) | |
| Return On Assets | (0.53) | (0.56) | |
| Return On Equity | (1.06) | (1.01) |
Things to note about Sana Biotechnology performance evaluation
Checking the ongoing alerts about Sana Biotechnology for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Sana Biotechnology help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Sana Biotechnology is way too risky over 90 days horizon | |
| Sana Biotechnology appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (266.76 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Sana Biotechnology currently holds about 484.8 M in cash with (223.15 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.57. | |
| Sana Biotechnology has a frail financial position based on the latest SEC disclosures | |
| Over 79.0% of the company shares are owned by institutional investors | |
| Latest headline from globenewswire.com: Sana Biotechnology to Present at December 2025 Investor Conferences |
- Analyzing Sana Biotechnology's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Sana Biotechnology's stock is overvalued or undervalued compared to its peers.
- Examining Sana Biotechnology's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Sana Biotechnology's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Sana Biotechnology's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Sana Biotechnology's stock. These opinions can provide insight into Sana Biotechnology's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Sana Stock analysis
When running Sana Biotechnology's price analysis, check to measure Sana Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sana Biotechnology is operating at the current time. Most of Sana Biotechnology's value examination focuses on studying past and present price action to predict the probability of Sana Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sana Biotechnology's price. Additionally, you may evaluate how the addition of Sana Biotechnology to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities |